Assuming cov is required, the following 8 results were found.
-
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
Sato from The University of Tokyo, Tokyo, Japan Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed a worldwide threat. The emergence of the BA.2.86 variant, a subvariant of Omicron, has raised significant...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
http://www.cdc.gov/coronavirus/mers/index.html
- Type: Category
-
13 March, 2024 As of March 1, 2024, the SARS-CoV-2 Omicron variant JN.1 was continuing to increase in prevalence in the United States, with CDC Nowcast projections estimating further increases in JN.1. At that time, JN.1 was projected to account for...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
is another Omicron variant closely related to BA.2.86, a subvariant that demonstrated the most recent large shift in SARS-CoV-2 evolution; JN.1 has >35 mutations in the spike protein as compared to the XBB.1.5 spike protein (Kaku, January 2024). Q: Is...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
of Federal Health Professionals. Zeng was honored during the AMSUS virtual annual meeting on Feb 24. In the early days of the COVID-19 pandemic, Zeng was the first scientist to quickly develop and validate highly reliable and sensitive molecular...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) have developed the first lethal mouse model of SARS-CoV-2, the virus that causes COVID-19. The model utilizes mice that were genetically engineered to express the human ACE2 gene–a...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Pathology
-
Virtual Campus Visit Located on our campus, the COVID-19 Clinical Research Center conducts innovative studies for participants who are positive for SARS-CoV-2, the virus that causes COVID-19. The CCRC offers the opportunity for collaboration by...
- Type: Article
- Author: Dr. Correo “Cory” Andrew Hofstad J.S.D MPHJD MSPH JD Ph.D. M.D. D.O. MBACOGS MDiv
- Category: Oncology
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.